Intestinal microbiota-dependent phosphatidylcholine metabolites, diastolic dysfunction, and adverse clinical outcomes in chronic systolic heart failure - Wikidata - wikimedia - TriplyDB

Intestinal microbiota-dependent phosphatidylcholine metabolites, diastolic dysfunction, and adverse clinical outcomes in chronic systolic heart failure

Intestinal microbiota-dependent phosphatidylcholine metabolites, diastolic dysfunction, and adverse clinical outcomes in chronic systolic heart failure

http://www.wikidata.org/entity/Q35034335

about

Systematic review regarding metabolic profiling for improved pathophysiological understanding of disease and outcome prediction in respiratory infections Listening to Our Gut: Contribution of Gut Microbiota and Cardiovascular Risk in Diabetes Pathogenesis Effect of Cardiac Resynchronization Therapy on Inflammation in Congestive Heart Failure: A Review Intestinal Microbiota Metabolism and Atherosclerosis Egg phospholipids and cardiovascular health The gut microbiome in cardio-metabolic health.Relationships between gut microbiota, plasma metabolites, and metabolic syndrome traits in the METSIM cohort.Impaired renal function and dysbiosis of gut microbiota contribute to increased trimethylamine-N-oxide in chronic kidney disease patients Elevated Circulating Trimethylamine N-Oxide Levels Contribute to Endothelial Dysfunction in Aged Rats through Vascular Inflammation and Oxidative Stress Microbiota-dependent metabolite and cardiovascular disease marker trimethylamine-N-oxide (TMAO) is associated with monocyte activation but not platelet function in untreated HIV infection.Lung Microbiota and Its Impact on the Mucosal Immune Phenotype.Intersections Between Microbiome and Heart Failure: Revisiting the Gut Hypothesis.Serum Trimethylamine-N-Oxide Is Strongly Related to Renal Function and Predicts Outcome in Chronic Kidney Disease Brief Report: Intestinal Microbiota-Produced Trimethylamine-N-Oxide and Its Association With Coronary Stenosis and HIV Serostatus.Exploring the Microbiome in Heart Failure Gut Microbiota in Cardiovascular Health and Disease.Emerging roles of flavin monooxygenase 3 in cholesterol metabolism and atherosclerosis Targeting of microbe-derived metabolites to improve human health: The next frontier for drug discovery.Trimethylamine N-Oxide Promotes Vascular Inflammation Through Signaling of Mitogen-Activated Protein Kinase and Nuclear Factor-κB.Intestinal Microbiota-Generated Metabolite Trimethylamine-N-Oxide and 5-Year Mortality Risk in Stable Coronary Artery Disease: The Contributory Role of Intestinal Microbiota in a COURAGE-Like Patient Cohort.Choline Diet and Its Gut Microbe-Derived Metabolite, Trimethylamine N-Oxide, Exacerbate Pressure Overload-Induced Heart Failure Associations among serum trimethylamine-N-oxide (TMAO) levels, kidney function and infarcted coronary artery number in patients undergoing cardiovascular surgery: a cross-sectional study Microbiota-Dependent Metabolite Trimethylamine N-Oxide and Coronary Artery Calcium in the Coronary Artery Risk Development in Young Adults Study (CARDIA)Trimethylamine N-oxide in atherogenesis: impairing endothelial self-repair capacity and enhancing monocyte adhesion.Gut Microbiota-Dependent Metabolite Trimethylamine N-Oxide Contributes to Cardiac Dysfunction in Western Diet-Induced Obese Mice.Circulating trimethylamine N-oxide and the risk of cardiovascular diseases: a systematic review and meta-analysis of 11 prospective cohort studies.Dietary Choline and Betaine and Risk of CVD: A Systematic Review and Meta-Analysis of Prospective Studies Gut Microbiota Metabolites and Risk of Major Adverse Cardiovascular Disease Events and Death: A Systematic Review and Meta-Analysis of Prospective Studies.Clinical Phenotyping of Heart Failure with Biomarkers: Current and Future Perspectives.The complex metabolism of trimethylamine in humans: endogenous and exogenous sources.Intestinal phospholipid and lysophospholipid metabolism in cardiometabolic disease.Microbiome, trimethylamine N-oxide, and cardiometabolic disease.Emerging roles of xenobiotic detoxification enzymes in metabolic diseases.Targeting the Microbiome in Heart Failure.Understanding the Holobiont: How Microbial Metabolites Affect Human Health and Shape the Immune System.Aberrant fecal flora observed in guinea pigs with pressure overload is mitigated in animals receiving vagus nerve stimulation therapy.Trimethylamine N-oxide: breathe new life.Gut Microbiota and Atherosclerosis.Measurement of the abundance of choline and the distribution of choline-containing moieties in meat.Trimethylamine N-oxide and prognosis in acute heart failure.

P2860

Q26782662-C78BFF48-4475-4404-A683-442594378796 Q26823198-1876EEF8-2313-47EA-AB5E-C7567D2AD593 Q27023183-55F91DC1-40D0-4C94-8437-A54693EFEEC3 Q28081862-84FD7F6F-F940-48E7-94B9-1D6C7EA50558 Q28082796-FD2CC61E-BAC9-4F3A-866C-9733417333C9 Q30373247-37D4FD6E-3E73-4AEA-AAAC-4B6FEC9543A4 Q33560362-E78CA3EF-B823-4D42-ADC2-8A75623934B1 Q33684162-C4FDBF20-F5CD-4FF2-8F11-9653F575F15F Q33736693-172146F4-E815-41F9-ACA7-4F022151F027 Q33827624-91C45ED5-3361-4194-AA12-411954143A71 Q33833225-BC55E186-3326-4036-BE4B-E5437333621A Q35798608-734EB81D-DC65-45FA-9FAB-77BEFD57366A Q35889821-3D82956A-88DD-4FDF-B7C7-62F840666C3D Q35908640-349F3FF1-6386-4F53-9B02-B56CFB5C73C0 Q35926145-6FDA6BF6-783C-4B50-A067-7A330A5874FD Q36329055-BE952205-C20A-4359-B952-EF815F7178A7 Q36337990-FA4C2675-4F46-4481-A2CD-95FFAA219B3A Q36340545-88FCB53A-40DA-420F-8519-D7029552CFAE Q36714031-A95ACCBD-F50F-4C60-A68D-34639A1CE835 Q37076037-17203983-9ABD-491C-9F93-C15A97B0406C Q37090184-6970A11F-ECFF-420C-80D7-00BABC068B2E Q37310131-676011F0-1A89-4BA4-B385-0781DE94F474 Q37434694-2ACA13F6-AA27-4044-B9AD-219BFB450C1E Q37677259-81325AC3-D6F5-4C05-BCE5-A2FC198F3232 Q37712604-EA9B5208-0DA1-448B-B258-55B080C51D17 Q38637363-B9935F44-0C66-4073-A662-C5AD6E1D46CE Q38689595-0A0D2F35-31B6-4981-AB6C-F90336B7CBB5 Q38701617-C0C4E46E-949E-464C-9C5A-96B7C2B500FF Q38756838-0334531F-8A1A-48DB-82BA-626CDEF9D79F Q38820418-078E9D7D-304D-4578-9107-2D68BADA02F9 Q38903367-2634B2D4-A881-445E-BD18-2CDABFF3F30D Q38918147-63C215AC-DA27-415F-83DA-97EE5F3F5975 Q39006153-47AD5639-A5DA-44C5-870E-95C8F4D26984 Q39186198-3DE525A7-B8F8-4C77-8418-B4C79AAF0D6E Q39381331-23533531-06A1-4DD2-B2DE-7578A6826243 Q39453162-B76FF8EF-0329-4A55-A827-C4A900E22627 Q39459129-BAE333D4-EBEE-4BE1-A62E-686CAB9DBEEB Q40079055-DABFEB15-C27C-4EA3-9676-2B265E5C8B64 Q40507285-9CE026D1-B0CC-412D-990E-F0954CDF058E Q40914356-51A8A70E-231A-4B15-9724-89CEC898828B

P2860

Intestinal microbiota-dependent phosphatidylcholine metabolites, diastolic dysfunction, and adverse clinical outcomes in chronic systolic heart failure

http://www.wikidata.org/entity/Q35034335

description

2014 nî lūn-bûn

@nan

2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Intestinal microbiota-dependen ...... chronic systolic heart failure

@ast

Intestinal microbiota-dependen ...... chronic systolic heart failure

@en

type

label

Intestinal microbiota-dependen ...... chronic systolic heart failure

@ast

Intestinal microbiota-dependen ...... chronic systolic heart failure

@en

prefLabel

Intestinal microbiota-dependen ...... chronic systolic heart failure

@ast

Intestinal microbiota-dependen ...... chronic systolic heart failure

@en

P1433

Q35034335-D7428F84-4D7B-4C41-A43D-20F9DE8AD686

P1476

Q35034335-5C2B3FB7-8407-45B1-BE06-2F08CC42742C

P2093

Q35034335-0153FADE-BA65-4B08-A6E6-420BAF0F661C

Q35034335-0AE1E390-93D9-48A8-8666-80D9F3DD86A4

Q35034335-1D041E5D-CFBA-4D99-87AB-283C48410321

Q35034335-1F7063E5-D8E6-46B1-ADEA-D4716D1B8E2C

Q35034335-A5AB275C-55EA-4B05-BEF8-92B5CAD79865

Q35034335-B843BA10-5ECD-431B-BEC2-C8CC3FAE6A60

Q35034335-DE10A8B3-80B9-4724-A1F7-B9B8BEDEA16F

P2860

Q35034335-1257C44D-227C-4CA6-90B1-71D4479A7FFB

Q35034335-1DC349FC-99EE-4FB6-A9D9-52E288B8BEE5

Q35034335-209121D9-B95E-4230-A9C0-A5928A9B1E15

Q35034335-4A4D6FE9-2F87-4E6D-8F59-73BFF16EF8F6

Q35034335-4BCCE5DA-8A48-4391-8D54-8992E59627B9

Q35034335-4BFB73A0-E2B5-4322-B888-2A3A9973DA73

Q35034335-79C894F7-4446-4B4E-A012-529032EF3D93

Q35034335-8C3B778D-D789-4549-8194-D91D9D5D62EF

Q35034335-8EB93E46-7A92-496D-899B-F4D4FE4BEEF7

Q35034335-A5C39570-6ADE-4561-BB22-EDA20F843168

P304

Q35034335-7C94EEEE-07D0-49E8-B721-2216A945749D

P31

Q35034335-2B3896BC-ECBB-42AE-BD3A-2FCE88662E20

P356

Q35034335-44BA3023-EDEA-4117-8C37-0495166321B0

P433

Q35034335-496B9E3A-E076-4D36-9DB0-4FADEAE3251E

P478

Q35034335-0E19EA79-AC5B-4E7F-8435-2624B9B11F7D

P50

Q35034335-975B045E-7A87-42E0-9CF4-61A5F720E7A8

P577

Q35034335-2A4AF451-9EB7-48F2-9685-43F9E661E014

P698

Q35034335-67793E6B-A6E7-4274-97D8-3AD56E9F4C7A

P921

Q35034335-1D6DBC06-93C4-425A-B9E7-F9968920B013

Q35034335-3215C15C-FB55-4D65-B707-887FDAF2097F

Q35034335-616E2166-95A4-43D8-BD68-3558D1C6D038

Q35034335-6D64B2E7-ED84-4FD4-9FA4-0FD4F9DF7245

P932

Q35034335-F60D6521-E089-49FC-9B92-3249127523D5

P356

J.CARDFAIL.2014.11.006

P1433

Journal of Cardiac Failure

P1476

Intestinal microbiota-dependen ...... chronic systolic heart failure

@en

P2093

Allan L Klein

http://www.w3.org/2001/XMLSchema#string

Allen G Borowski

http://www.w3.org/2001/XMLSchema#string

Kevin Shrestha

http://www.w3.org/2001/XMLSchema#string

Richard W Troughton

http://www.w3.org/2001/XMLSchema#string

Stanley L Hazen

http://www.w3.org/2001/XMLSchema#string

W H Wilson Tang

http://www.w3.org/2001/XMLSchema#string

Yuping Wu

http://www.w3.org/2001/XMLSchema#string

P2860

Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease

Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk

Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis

Measurement of trimethylamine-N-oxide by stable isotope dilution liquid chromatography tandem mass spectrometry.

The importance of the gastrointestinal system in the pathogenesis of heart failure.

Temporal variations of the ileal microbiota in intestinal ischemia and reperfusion.

Prognostic value of elevated levels of intestinal microbe-generated metabolite trimethylamine-N-oxide in patients with heart failure: refining the gut hypothesis.

The emerging role of the gut in chronic heart failure.

Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice.

Prognostic value of choline and betaine depends on intestinal microbiota-generated metabolite trimethylamine-N-oxide

P304

91-96

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.CARDFAIL.2014.11.006

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

21

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-11-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25459686

http://www.w3.org/2001/XMLSchema#string

P921

phosphatidylcholines

P932

4312712

http://www.w3.org/2001/XMLSchema#string